Bionime Corporation operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bionime with three other
pharmaceutical manufacturers in Asia:
Mizuho Medy Co Ltd
sales of 4.96 billion Japanese Yen [US$44.01 million]
Nissui Pharmaceutical Co., Ltd.
(12.02 billion Japanese Yen [US$106.58 million]
of which 43%
was Clinical diagnostics business), and
Kainos Laboratories, Inc.
based in Japan
(5.35 billion Japanese Yen [US$47.42 million]
During the year ended December of 2016, sales at
Bionime were 1.74 billion Taiwanese Dollars (US$57.00 million).
increase of 8.1%
versus 2015, when the company's sales were 1.61 billion Taiwanese Dollars.